1/83
Looks like no tags are added yet.
What happens to citrate when ATP and insulin is high
Citrate shuffle
Citrate moves out of mitochondria and into cytoplasm
Start of fatty acid synthesis
Where does citrate come from
Product of citric acid cycle
What happens to excess glucose
Turns into fat and stored as adipose tissue as triglyceride
Triglyceride
Glycerol + 3 fatty acids
Saturated fatty acid
No double bonds
Packed tightly
Linked to clogged arteries
Mono/poly unsaturated fatty acids
Double bonds create kinks
Packed loosely
Linolenic acid
Essential
Precursor of omega-3
Lowers triglycerides and prevents blood clot formation
Linoleic acid
Essential
Precursor of omega-6
Lowers LDL (low density lipoproteins)
Oleic acid
Conditionally essential
Body only makes a minute amount
Arachidonic acid
Conditionally essential
Used for prostaglandin synthesis
Can be made from linoleic acid
Relate FAs to cell membranes
Essential FAs are structural components of cell membranes (membrane function and stability)
LDL
Low-density lipoprotein
Carries cholesterol from the liver to body tissues
Bad cholesterol (associated with clogged arteries)
Eicosanoids
signaling molecules made from arachidonic acid
COX pathway
A metabolic pathway that produces prostaglandins and thromboxane from arachidonic acid via cyclooxygenase enzymes
Prostaglandins
An eicosanoid signaling molecule made from Arachidonic acid through the COX pathway that helps regulate inflammation, pain, and other body functions
Thromboxane
An eicosanoid made through the COX pathway from Arachidonic acid that helps blood clot formation
How does NSAIDs affects COX pathway
Inhibit COX
results in less prostaglandin and less thromboxane
Lipoproteins
Particle made of lipids + proteins that transports fats thrrough the blood steam
Chylomicron
A lipoprotein in the Gut/intestine
Exogenous (fat it carries is from diet alone)
carried fat is dietary triglycerides
VLDL
A lipoprotein in the liver
Endogenous (fat it carries is made by the body)
Carried fat is triglycerides made by the liver
LPL
Lipoprotein lipase
An enzyme on capillary walls used to break down Chylomicrons and VLDLs
Activated by Apo C-II
Releases fatty acids into the bloodstream to be delivered to muscle or adipose tissue
Chylomicron remnant
What remains after its breakdown
Taken back up by the liver
VLDL remnant
What remains after its breakdown
Taken up by the liver
Can be further metabolized into LDL
LPL or Apo C-II deficiency
Body can’t breakdown chylomicrons/VLDL
Chylomicrons accumulate in plasma
Causes rise in triglycerides
increased risk of acute pancreatitis (abdominal pain)
Nonalcoholic fatty liver disease (MASLD)
Imbalance between hepatic TG (triglycerides) synthesis and VLDL secretion
Linked to obesity and type II diabetes
Stages: Imflammation → fibrosis → cirrhosis (irreversible) → liver failure
Cholesterol synthesis
Acetyl-CoA → HMG CoA → Mevalonate → Cholesterol
Key enzyme is HMG CoA reductase
Acetyl-CoA can come from beta-oxidation
HMG CoA reductase
Enzyme used to convert HMG CoA → Mevalonate
Activated by Insulin
Inhibited by glucagon and statin drugs
Triglyceride lipolysis
The breakdown of stored fat so the body can use it
Lipase breaks down stored adipose triglycerides into glycerol and fatty acids
Glycerol: travels to liver where its converted to glycerol-3-phosphate (which can enter gluconeogenesis)
Fatty Acids: undergo beta-oxidation, which breaks them down into Acetyl-CoA (produces ATP)
Beta-oxidation
The process of breaking down fatty acids into Acetyl-CoA
Acetyl-CoA enters Citric Acid Cycle (which produces Oxaloacetate that can be used for gluconeogenesis)
NADH and FADH2 carry electrons to ETC for ATP production
happens in mitochondrial matrix
Carnitine shuttle
A transport system that moves long chained fatty acids into the mitochondrial matrix so they can undergo beta-oxidation
Needed because long chained fatty acids cannot cross membrane on their own
Insulin affect on carnitine shuttle
Inhibits shuttle
High insulin means enough E present, so no needed to burn fat
Carnitine/CPT deficiency
Fatty acids can’t enter mitochondria - beta-oxidation decreases
Free FA accumulation in blood
Low ketone bodies (less beta-oxidation means less acetyl-Coa available to make ketones)
Fasting Hypoglycemia (body can’t use fat for E so keeps burning glucose)
Symptoms: lethargy, extreme sleepiness, vomiting
when do we make ketone bodies
During fasting, starvation, prolonged low carbohydrate intake, or uncontrolled diabetes: low insulin, high glucagon/epinepherine
Excess Acetyl-CoA converted to ketones (after TCA cycle uses what it needs)
where are ketone bodies made
Mitochondria in Liver
2 Acetyl-CoA → acetoacetyl CoA → HMG CoA → acetoacetate
Acetoacetate
Ketone body
Used for Energy
Transported in the blood to peripheral tissues
3-Hydroxybutyrate
Ketone body
Used for Energy
Reconverted to Acetyl-CoA and oxidized by TCA
Acetone
Ketone body
Metabolic dead end
Not used for Energy
Made spontaneously from acetoacetate and exhaled
Function of ketone bodies
Alternative fuel source when glucose is low
Made from Acetyl-CoA (from triglyceride breakdown)
Brain can’t use fatty acids, but can use ketones because they can cross the blood-brain barrier
Ketone effects on brain
When there are ketones in the brain, the brain can rely more on ketones than glucose for E source
Decreased glucose demand → decreased muscle breakdown
Muscle protein is reserved
Ketosis
Metabolic state where body breaks down more fat and the liver produces ketone bodies for E because carb availability is low
Happens during fasting, prolonged exercise, or low carb diet
Ketoacidosis
A dangerous build up of ketones that makes the blood too acidic
Associated with uncontrolled diabetes
Signs: extreme thirst, frequent urination
What diseases come from defective lipid metabolism
Gauchers
Niemann-Pick
Tay-Sachs
Krabbe
Transanimation
Transfers an amine group to make new non-essential AAs
requires Vitamin B6
Enzyme used: Aminotransferase
Deanimation
Breaks down AA’s and releases toxic amine groups
Releases ammonia
Liver converts ammonia into urea through the urea cycle
Urea Cycle
Cycle that converts toxic ammonia into non-toxic urea and excreted as urine
Occurs in liver (partly in mitochondria, partly in cytoplasm)
Enzymes used in Urea Cycle
Ornithine transcarbamylase (OTC)
Carbamoyl phosphate synthetase I (CPS I)
Argininosuccinate synthetase
Argininosuccinate lyase
What happens when defect in any of the 4 enzymes in the Urea Cycle?
Results in toxic ammonia (hyperammonia) in system
Usually noticed in infancy
OTC defects are the most common urea cycle disorder
Citrullinemia
genetic disorder caused by defected Argininosuccinate synthetase
Reye syndrome
Associated with urea cycle enzyme deficiency
Hyperammonemia, liver failure, hypoglycemia, encephalopathy
BUN (blood urea nitrogen) test
Test to measure urea in blood to assess kidney function/damage and effectiveness of dialysis
Phenylketonuria (PKU)
AA metabolism disorder
Affected AA: Phe, Tyr
Effects: Intellectual disability, microcephaly, decreased skin/hair pigmentation, musty odor
Treatment: dietary restructions of Phe
Oculocutaneous albinism
AA metabolism disorder
Affected AA: Tyr
Effects: lack of melanin: white hair, very pale skin, light-colored irises
Alkaptonuria
AA metabolism disorder
Affected AA: Tyr
Effects: Dark urine, pigmented sclera (ochronosis)
Cystinuria
AA metabolism disorder
Affected AA: Cys
Effects: Excess urinary cysteine, kidney stones
Homocystinuria
AA metabolism disorder
Affected AA: Met
Effects: Myopia, marfan-like skeletal changes, DVT, intellectual disability, scoliosis
Maple syrup urine disease (ketoacidemia)
AA metabolism disorder
Affected AA: Ile, Leu, Val
Effects: Intellectual disability, ketosis, seizures
Heme synthesis
ALA synthase: glycine + succinyl-CoA → ALA (occurs in mitochondria. requires Vitamin B6)
ALA dehydratase: Helps convert ALA to next intermediate. (inhibited by Lead)
Several steps → protoporphyrin IX
Ferrochelatase (heme synthase): Adds Fe2+ to protoporphyrin IX → heme (Inhibited by Lead)
What enzymes does Lead target?
ALA dehydratase
Ferrochelatase
Vitamin B6 deficiency
Affects heme synthesis because vitamin B6 is needed in first step
Results in sideroblastic anemia: skin rashes, cracked and sore lips, sore and glossy tongue)
Lead Poisoning
Inhibits ALA dehydratase and ferrochelatase (affects heme synthesis)
Results in sideroblastic anemia
Lead line can be seen at the gumline
Iron deficiency
Affects heme synthesis because iron is used in last step
Results in microcytic hypochromic anemia
Bilirubin
A yellow waste product made from old RBC when they are broken down
Too much can cause jaundice
Very high levels can cause Kernicterus
Kernicterus
Caused by very high levels of bilirubin
damages the brain
Effects: cerebral palsy, hearing loss, intellectual disability, stains on enamel of primary teeth
Treatment: Phototherapy, IVIg, exchange transfusion
Steatosis (fatty change) accumulation
Abnormal fat accumulation in cells (typically liver)
Often reflects damage to lipid transport
Seen in alcholism/binge drinking, malnutrition, diabetes, obesity (MASLD)
Caused by increase FFA synthesis, decrease FA oxidation, decrease lipoproteins
Amyloid accumulation
Misfolded beta-pleated sheet protein deposited in tissue
Seen in amyloidosis, multiple myeloma, Alzheimer’s, and some tumors
Anthracosis accumulation
Inhaled carbon particles stored long term in lung macrophages (air pollution/ smoking)
Discolors bronchial mucosa black
Lipofuscin accumulation
“wear and tear” pigment
insoluble brown particles of oxidized lipid and protein from membrane turnover
builds up with age and chronic inflammation
Hemosiderin accumulation
Golden brown, iron-containing pigment from the breakdown of hemoglobin (hemolysis, RBC breakdown)
Pyknosis
Nucleus shrinks (becomes dense with condensed chromatin)
Karyorrhexis
Nucleus fragments/breaks apart
Karyolysis
Nucleus dissolves and fades
Coagulative tissue necrosis
Tissue architecture is preserved, but cells are dead
Usually caused by ischemia (loss of blood supply)
tissue pale but firm
Liquefactive tissue necrosis
Dead tissue dissolves into liquid
Common in tissues with many lysosomes (brain)/ bacterial infection
pus
Caseous tissue necrosis
Soft, crumbly, cheese-like tissue
Cell outline lost but not fully lysed
pink granular debris at center of a granuloma
Classically seen in TB
Gummatous tissue necrosis
Dead tissue is rubbery and surrounded by granulomatous inflammation
noncancerous growth
seen in syphilis
Hemorrhagic tissue necrosis
Dead tissue full of RBC
Often due to venous obstruction while arterial supply remains
Enzymatic fat necrosis
Pancreatic enzymes (lipases) escape and break down fat into fatty acids
FA binds to calcium in surrounding tissue
Forms chalky soap like substances (saponification)
Ex. acute pancreatitis
Labile tissue
Constantly dividing
stem cells readily avaialble
regenerate after injury as long as enough stem cells remain
Ex. skin, oral mucosa, gut lining, hematopoietic tissue
Stable tissue
Normally divide only rarely
Can be stimulated to divide after injury
contain progenitor cells for faster renewal
Ex. glands, liver, kidney, most connective tissue
Permanent tissue
Terminally differentiated
Cannot re-enter the cell cycle or regenerate
heal only by fibrosis (scarring)
Ex. nerve cells, skeletal muscle, cardiac muscle
Granulation tissue
A tissue type formed during repair
Made of proliferating fibroblasts and fragile new capillaries
Occur during early stages of healing
Granuloma
A collection of immune cells that walls off something hard to eliminate (focal pattern of chronic inflammation)
Made of organized clusters of activated macrophages
Occurs in chronic inflammation (TB, syphilis)
Primary intention
Describes healing wounds with edges close together (well sutured incision)
Healing is swift and clean
minimal scarring
Secondary intention
Describes healing wounds with edges far apart (wide open with tissue loss)
Healing is slower. Fills in from the base with granulation tissue
Scarring is more obvious